Michelle Chen

Michelle Chen is the current Chief Business Officer at Insilico Medicine. Prior to their current position, they worked as the Senior Vice President of Corporate Development and Managing Director of WuXi Biologics from April 2019 to October 2021. In this role, they were in charge of corporate development, strategies, M&A, licensing, strategic partnerships, joint ventures, newco formation, and investor communication in US & Europe. Michelle has also worked as the Corporate and Business Development at BioMarin Pharmaceutical Inc. from February 2018 to April 2019 where they were responsible for global In and Out licensing and partnering activities. Michelle is experienced in developing corporate strategies, negotiating transactions, and managing key alliances.

They are on a team with Alex Aliper - Co-Founder & President, Min Fang - Managing Director of Healthcare, and Jimmy Yen-Chu Lin - CEO, Insilico Medicine Taiwan. Their manager is Alex Zhavoronkov, Founder & CEO.